Skip to content
For laboratory research use only · Not for human consumption
Pioneer Labs

Blends / Research guide

KLOW.

A little deeper. A clearer picture.

Four components, with an extra tripeptide in the formulation. Each 80mg vial of KLOW holds 50mg GHK-Cu and 10mg each of BPC-157, TB-500 (the 43-amino-acid form) and KPV.

For research use onlyView KLOW sizes
Published by Pioneer LabsUpdated Sources & editorial standards

01 / Composition

KLOW vs GLOW, side by side.

KLOW is GLOW plus one component, the KPV tripeptide. The table lists what each vial holds, by mass. No synergistic effect is established by combining the components.

KLOW and GLOW, per vial
ComponentKLOWGLOW
GHK-Cu50mg50mg
BPC-15710mg10mg
TB-500 (43-amino-acid form)10mg10mg
KPV10mgNone
Total per vial80mg70mg
Amounts by mass, as formulated. Match your lot’s certificate to them.

02 / Molecular architecture

A closer look at the components.

KPV contributes a Lys–Pro–Val sequence alongside a copper-peptide complex and the other peptide components. These molecules do not become one longer chain when combined.

Pioneer / Reference notesComponent map
  • GHK-Cu · copper complex
  • BPC-157 · 15 residues
  • TB-500 · 43 amino acids
  • KPV · 3 residues
Components shown separately. This is a component list, not a chemical structure or a molecular ratio.

Reference information: [1][2][3][4][5][6][7]. Actual lot identity must be verified separately.

What the fourth component changes.

KLOW names a formulation containing the GLOW component set plus KPV. KPV remains a separate tripeptide; it is not an extension attached to GHK, BPC-157 or TB-500. The formulation therefore requires four component identities rather than one combined sequence diagram.

What a composition table leaves out.

The KLOW vs GLOW table compares the two blends by mass: which components each vial holds, and how many milligrams of each. It does not rank the blends, describe how their components behave together or count molecules, since each component has its own molecular mass. That comparison concerns composition only.

Structure and research references: [1][2][3][4]

03 / Read the evidence

Research & analytical context.

The references address the individual components; the TB-500 reference studied a short thymosin beta-4 fragment rather than the 43-amino-acid form used here. KPV adds a separate three-residue peptide to the GLOW component set; it does not extend any of the other chains. These sources do not establish the identity, proportions or stability of a finished KLOW mixture.

Read the references: [1][2][3][4][5][6][7].

The distinction that matters

KLOW is a blend name, not a standardized molecular identity. Match your lot’s certificate to the amounts in the KLOW vs GLOW table, and read its formulation-specific results, before comparing KLOW with another blend.

04 / From reference to record

Know the lot, too.

A publication describes its own test material. Your lot’s certificate describes what was tested on that lot. Keep the compound name, batch number and reported methods together when reviewing a result.

Identity & composition

Check sequence or chemical form, terminal modifications, counterion and—where relevant—each blend component.

Analytical results

Read purity, content, sterility and endotoxin results as separate measurements. Only call a test passed when the actual report supports it.

Handling & storage notes

Lyophilized material: Store at −20°C; protect from light and moisture.

Follow the material-specific label and supporting storage documentation. These temperatures do not establish a shelf life.

How to store lyophilized peptides

05 / Reference questions

A few details, explained.

Does the name KLOW define a fixed composition?

Here it does: the KLOW vs GLOW table on this page gives the amount of every component in each 80mg vial. It is still a blend name rather than a standardized molecular formula, so match your lot’s certificate to that composition.

Is KPV part of one of the other chains?

In this formulation it is a separate named component. Mixing peptides together does not chemically join their backbones into a larger peptide.

Read alongside the references: [1][2][3][4]

06 / Continue reading

Go to the source.